MDPI |
Multidisciplinary Digital Publishing Institute |
MTHFR |
5,10-methylenetetrahydrofolate reductase; Methylenetetrahydrofolate reductase |
NTDs |
Neural tube defects |
5,10-methylene-THF |
5,10-methylenetetrahydrofolate |
5-methyl-THF |
5-methyltetrahydrofolate |
NADPH |
Nicotinamide adenine dinucleotide phosphate |
FAD |
Flavin adenine dinucleotide |
Hcy |
Homocysteine |
Met |
Methionine |
MS |
Methionine synthase |
THF |
Tetrahydrofolate |
5,10-MTHF |
5,10-methylenetetrahydrofolate |
5-MTHF |
5-methyltetrahydrofolate |
SAM |
S-Adenosyl-L-methionine |
SAH |
S-Adenosyl-L-homocysteine |
dTMP |
Deoxythymidine monophosphate |
DNA |
Deoxyribonucleic acid |
CBS |
Cystathionine β-synthase |
SNPs |
Single nucleotide polymorphisms |
Ala |
Alanine |
Val |
Valine |
Glu |
Glutamine |
HHcy |
Hyperhomocysteinemia |
A |
Adenine |
C |
Cytosine |
T |
Thymine |
G |
Guanine |
NO |
Nitric Oxide |
NMDA |
N-methyl-D-aspartate |
PP2A |
Protein phosphatase 2A |
ALP1 |
Apolipoprotein 1 |
EC |
Endothelial cells |
IL-1β |
Interleukin 1 β |
IL-6 |
Interleukin 6 |
IL-8 |
Interleukin 8 |
TNF-α |
Tumor necrosis factor |
ROS |
Reactive oxygen species |
NF-κB |
Nuclear factor kappa B |
CVD |
Cardiovascular disease |
IMH |
Intramural hematoma |
OR |
Odds Ratio |
CI |
Confidence Interval |
BC |
Breast cancer |
HER-2 |
Receptor tyrosine-protein kinase erbB-2 |
PC |
Prostate cancer |
OC |
Ovarian cancer |
CLL |
Chronic lymphocytic leukemia |
ALL |
Acute lymphocytic leukemia |
AML |
Acute myeloblastic leukemia |
CML |
Chronic myeloblastic leukemia |
ASD |
Autism Spectrum Disorder |
Fragile X |
Fragile X Messenger Ribonucleoprotein 1 |
SHANK 3 |
SH3 and multiple ankyrin repeat domains 3 |
CASPR 2 |
Contactin-associated protein-like 2 |
RFC1 |
Replication factor C subunit 1 |
FRα |
Folate receptor α |
PCFT |
Proton-coupled folate transporter |
AD |
Alzheimer’s disease |
EOAD |
Early-onset Alzheimer’s disease |
LOAD |
Late-onset Alzheimer’s disease |
APP |
Amyloid precursor protein |
PSEN1 |
Presenilin 1 |
PSEN2 |
Presenilin 2 |
APOE |
Apolipoprotein E |
aMCI |
amnestic Mild Cognitive Impairment |
SCZ |
Schizophrenia |
MDD |
Major Depressive Disorder |
TRD |
Treatment-Resistant Depression |
FDA |
The United States Food and Drug Administration |
MID |
Migraine with comorbid depression |
PD |
Parkinson’s disease |
L-DOPA |
L-3,4-dihydroxyphenylalanine |
ADHD |
Attention deficit hyperactivity disorder |
DM |
Diabetes mellitus |
T2DM |
Type 2 diabetes mellitus |
IR |
Insulin resistance |
DN |
Diabetic nephropathy |
DR |
Diabetic retinopathy |
DPN |
Diabetic peripheral neuropathy |
GDM |
Gestational diabetes mellitus |
MS |
Metabolic syndrome |
ER |
Endoplasmic reticulum |
NAFLD |
Non-alcoholic fatty liver disease |
NASH |
Non-alcoholic steatohepatitis |
IBD |
Inflammatory bowel disease |
CD |
Crohn’s disease |
UC |
Ulcerative colitis |
U-IBD |
Unclassified inflammatory bowel disease |
DNMTs |
DNA methyltransferases |
RPL |
Recurrent pregnancy loss |
PE |
Pre-eclampsia |
PTB |
Preterm Birth |
LBW |
Low birth weight |
UMFA |
Unmetabolized folic acid |
RA |
Rheumatoid arthritis |